Dawn Talk
The Dawn of a Digital Industry
With Sobia Akram, Corporate Vice President, Global Business Ethics Compliance Office & Programme at Novo Nordisk.
In this Dawn Talks, our CEO and founder, Daniel Daugaard, sits down with Sobia Akram, Corporate Vice President, Global Business Ethics Compliance Office & Programme at Novo Nordisk. They discuss the early beginnings of Dawn Health and the impact of COVID-19 on the industry, the role of SaMD in clinical trials, RWE, outcome-based reimbursement, data privacy, business ethics, and having a quality mindset.
Talking points
COVID-19
SaMD in Clinical Trials
RWE
Reimbursement
Data Privacy
Business ethics
Interested in doing a talk?
Get in touch